Newsroom
Sorted by: Latest
-
Los Tigres del Norte Support St. Jude Children’s Research Hospital In Celebration of El Dia del Niño
MEMPHIS, Tenn.--(BUSINESS WIRE)--Latin music legends Los Tigres del Norte recently visited St. Jude Children’s Research Hospital® for the first time, as part of the Music Gives to St. Jude Kids® initiative. The multiple Grammy Award-winning group toured the research hospital and learned about the work taking place at St. Jude. The band also spent time with patients and families, getting to know them through discussions of music and over a game of Lotería, a traditional Mexican game similar to b...
-
Keller Williams Names Christopher Brodhead as Chief Revenue Officer
AUSTIN, Texas--(BUSINESS WIRE)--Brodhead will lead the company’s revenue growth strategy, reinforcing KW’s position as the place where real estate entrepreneurs thrive....
-
Union Pacific’s Big Boy to Tour the Northeast for First Time in Honor of America’s 250th Anniversary
OMAHA, Neb.--(BUSINESS WIRE)--Union Pacific’s famed Big Boy No. 4014, the world’s largest operating steam locomotive, will journey to the East Coast for the first time in collaboration with Norfolk Southern, as part of a historic coast-to-coast tour as both railroads celebrate America’s 250th anniversary. The tour includes a Fourth of July celebration in Philadelphia, major display events in eight cities and more than 50 whistle-stops in 10 states, including stops for the first time in Indiana,...
-
ProcessMiner Raises Seed Funding to Scale AI-Powered Optimization for Manufacturing, Critical Infrastructure End-Markets
ATLANTA--(BUSINESS WIRE)--ProcessMiner, a leader in AI-powered process optimization for manufacturers, today announced new seed funding led by Titanium Innovation Investments. The investment will fuel expansion of ProcessMiner’s platform, accelerate hiring, and deepen the company’s commitment to bringing intelligent process optimization solutions to manufacturing and critical infrastructure end-markets across the globe. This first external funding round marks a significant milestone for Process...
-
Experian Meets the Next Generation with First 'AI Sponsored Snaps' to promote Financial Education on Snapchat
COSTA MESA, Calif.--(BUSINESS WIRE)--Experian® today announced it plans to expand access to trusted financial education by integrating into Snapchat’s AI Sponsored Snaps ad offering....
-
Digital.ai Appoints Craig Jones as Chief Revenue Officer
RALEIGH, N.C.--(BUSINESS WIRE)--Digital.ai, which helps the world's most complex organizations deliver trusted software at AI speed, today announced the appointment of Craig Jones as Chief Revenue Officer. Jones will oversee Digital.ai's global revenue growth strategy, including sales, customer success, sales engineering, business development, and revenue operations. A multiple-time CRO, Jones brings more than 25 years of experience scaling enterprise commercial organizations across direct and...
-
Tombot’s Robotic Companion Jennie Makes Film Debut in “Walkies,” A Story of Healing & Connection
SANTA CLARITA, Calif.--(BUSINESS WIRE)--Tombot’s Robotic Companion Jennie Makes Film Debut in “Walkies,” A Story of Healing & Connection...
-
2026 Private Company Boards of the Year From MLR Media
PHILADELPHIA--(BUSINESS WIRE)--Seven private company boards have been honored with Private Company Boards of the Year awards for their business governance excellence by MLR Media. The awards will be presented at the 2026 Private Company Governance Summit®, which will take place June 10-12, 2026, at The Westin DC Downtown in Washington, D.C. The boards of these companies were selected for recognition: Benco Dental U.S. Venture Inc. Edmund Optics Wyo-Ben Inc. ThermFlo Inc./Zonatherm Products King...
-
Riassunto: Taiho Oncology, Taiho Pharmaceutical e Araris Biotech AG portano l'ADC ARC-02 nella fase 1 di sviluppo clinico
PRINCETON, New Jersey, TOKYO e ZURIGO--(BUSINESS WIRE)--Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd. e Araris Biotech AG ("Araris") oggi hanno annunciato il completamento del periodo di revisione relativo a un nuovo farmaco sperimentale (IND) da parte della U.S. Food and Drug Administration (FDA) su ARC-02, un anticorpo farmaco-coniugato (ADC) in corso di sviluppo per il trattamento dei linfomi non Hodgkin. Taiho Oncology può così dare inizio a uno studio clinico di fase 1 su ARC-02 con...
-
Resumen: Taiho Oncology, Taiho Pharmaceutical y Araris Biotech AG inician la fase 1 de desarrollo clínico del ARC-02, un conjugado de anticuerpo y fármaco (ADC)
PRINCETON, Nueva Jersey; TOKIO; y ZÚRICH--(BUSINESS WIRE)--Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd. y Araris Biotech AG (“Araris”) anunciaron hoy que la Administración de Alimentos y Medicamentos de Estados Unidos (FDA) ha completado el período de revisión de un nuevo fármaco en investigación (IND) para ARC-02, un conjugado de anticuerpo y fármaco (ADC) en desarrollo para el tratamiento del linfoma no Hodgkin, lo que permite a Taiho Oncology iniciar un ensayo clínico de fase 1 con e...